MedCu Technologies is the world’s first and only Copper wound dressing provider that got the CE certificate and FDA clearance for marketing.
The copper wound dressing is impregnated with copper particles. This pioneering implementation of copper properties has been developed in over 15 years of intensive research and is protected by over 30 patents, globally. MedCU delivers antimicrobial dressing products that provide an antimicrobial barrier for bacteria contamination, while concurrently supporting the healing process. Such products are ideal for acute, diabetic and chronic wounds.
MedCU wound dressing products are superior attractive alternative to the silver-based dressing that is widely available in the market. While providing superior antimicrobial benefits, they bring more benefits to patients and are a cost effective solution. The market of antimicrobial wound dressing is estimated at $1.9n in 2019.
Copper is a natural mineral essential to the human body. It has a long history of medicinal use based on its antimicrobial effect dating back to ancient times.
The MedCu Wound Dressing contains few non-woven layers, all of which are impregnated with copper oxide particles. Dressings are non-irritant, non-sensitizing, and are available in three configurations, with or without an adhesive contour.
MedCu Technologies will begin to market its dressing products in 2019 in North America and Europe and is currently also seeking international distributors.